Patients with prostate cancer had higher levels of LIF within their serum compared to serum of patients with benign prostatic hypertrophy and healthy patients, and serum LIF levels were even more elevated in cases of metastasis to bone [109]. Here, LIF is linked to prostate carcinoma.